CLINICAL_TRIALS
trial_result
· 2015-03-06
Clinical Trial Update: Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients [Phase 1]
Summary
Phase 1 trial evaluating the safety and tolerability of CTX-4430 in cystic fibrosis patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celtaxsys, Inc. | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED